-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Pharma-Bio Serv, Inc. quarterly/annual Revenues history and growth rate from 2017 to 2023.
- Pharma-Bio Serv, Inc. Revenues for the quarter ending July 31, 2024 was $2.42M, a 47.2% decline year-over-year.
- Pharma-Bio Serv, Inc. Revenues for the twelve months ending July 31, 2024 was $10.8M, a 40.2% decline year-over-year.
- Pharma-Bio Serv, Inc. annual Revenues for 2023 was $17M, a 12.5% decline from 2022.
- Pharma-Bio Serv, Inc. annual Revenues for 2022 was $19.4M, a 3.56% decline from 2021.
- Pharma-Bio Serv, Inc. annual Revenues for 2021 was $20.1M, a 6.72% decline from 2020.